New drug admin codes now components of cardio codes in CCI

Why This Topic Matters

The update affects how drug administration services are grouped with multiple cardiology procedure families under CCI. Understanding the scope of the edits helps coding and compliance teams review claims edits for the 2005 effective date and identify where modifier editing may apply.

Article Sections

1. Overview of the CCI update

   Introduces the new National Correct Coding Initiative version and the general context for the drug administration updates. It also identifies the effective date and the broad cardiology-related areas impacted.

2. Drug administration codes linked to pacemaker, nuclear cardiology, and other cardiology services

   Summarizes the first group of drug administration codes and the cardiology code families discussed in relation to the CCI edits. The section covers multiple procedural categories and notes the modifier indicator status.

3. Additional drug administration codes and related cardiology services

   Describes another group of drug administration codes and the broader set of cardiology procedure families associated with the edits. It includes the additional relationships and the modifier indicator status.

4. Change in modifier indicator for an additional component code

   Notes a change in modifier indicator status for a separately identified code and the cardiology procedure groups affected by that change. The section is limited to the edit relationship update.